All articles by Adam Zamecnik
Adam Zamecnik is a healthcare reporter for Pharmaceutical Technology. He has covered diverse topics such as continuous drug manufacturing, genomic research and sexual health. He is particularly interested in new technologies, health inequality, and cell and gene therapy research.
Adam Zamecnik
@a_zamecnik
UK rejoins EU’s Horizon Europe science programme
The country returns to the EU’s research programme after a Brexit-related absence and questions surrounding its re-entry prospects.
Tapping into digital therapeutics to improve neurological outcomes
Despite advancing research, clinical data and timely reimbursement are crucial for digital therapeutics in neurology.